The landscape of dementia prognosis has evolved radically with the advent of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology a long time in advance of signs or symptoms emerge. While these technological advancements symbolize remarkable development in comprehending neurodegenerative health https://aleisters753scm3.blogpayz.com/profile